The CPhI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts. Running as a series of opinions and articles, the CPhI experts call upon their considerable commercial and technical acumen to prophesize the future direction, technologies, opportunities and threats in pharma. It’s an essential read for executives who wish to get a head start today on the shape of tomorrow’s industry.
We would like to thank the following global pharma experts for contributing to the CPhI Annual Report 2017:
- Gil Roth, President at PBOA
- Alan Sheppard, Principal at IMS Health
- Vivek Sharma, CEO at Piramal Enterprises Ltd.
- Ajaz Hussain, Founder CEO at Insight Advice & Solutions LLC
- Dr Minzhang Chen, CEO at STA Pharma (Wuxi AppTec) and Sam Tadayon, Executive Director at STA Pharma (Wuxi AppTec)
- Dilip Shah, CEO at Vision Consulting Group
- Brian Carlin, Director at FMC
- Emil Cuirczak, President at Doramaxx Consulting
- Bikash Chatterjee, President and CSO at PharmTech Associates
- Girish Malhotra, President at EPCOT International
- BSV Prasad, Senior Vice President & Head, Small Molecules Business at Biocon